Search Results - "Burchert, Andreas"

Favorable Rates of Cardiovascular Events with Stringent Cardiovascular Monitoring and a Lowered Dose of Ponatinib as Second-Line Treatment in Chronic Phase Chronic Myeloid Leukemia Patients Failing or Intolerant to First-Line Second-Generation Tyrosine Kinase Inhibitor Treatment: Results of the Prospective PONS Trial

Authors: le Coutre, Philipp Burchert, Andreas Saußele, Susanne et al.

Source: Acta Haematologica. 2026, Vol. 149 Issue 3, p355-362. 8p.

Prospective Assessment of Treatment-Induced Liver Injury as a Cause of Diffuse Pathologic Hepatic Enhancement in Contrast-Enhanced Ultrasound.

Authors: Wiemers, Hannah Burchert, Andreas Michel, Christian et al.

Source: Ultrasound in Medicine & Biology. Feb2024, Vol. 50 Issue 2, p224-228. 5p.

Subjects: Contrast-enhanced ultrasound, Hematopoietic stem cell transplantation, Liver injuries

This result is not displayed to guests.
Login for full access.

Presentation of extramedullary myeloma manifestations on B-mode (B-US) and contrast-enhanced ultrasound (CEUS).

Authors: Trenker, Corinna Görg, Christian Burchert, Andreas et al.

Source: Journal of Ultrasonography. Apr2025, Vol. 25 Issue 101, p1-6. 6p. 2 Color Photographs, 1 Chart, 3 Graphs.

Pathologic Hepatic Contrast-Enhanced Ultrasound Pattern in Patients Undergoing Allogeneic Stem Cell Transplantation.

Authors: Trenker, Corinna Burchert, Andreas Schumacher, Caren et al.

Source: Ultrasound in Medicine & Biology. Aug2020, Vol. 46 Issue 8, p1865-1871. 7p.

Subjects: Stem cell transplantation, Contrast-enhanced ultrasound, Opacity (Optics), Hepatic veno-occlusive disease

Interferon α and T-cell responses in chronic myeloid leukemia.

Authors: Burchert, Andreas Neubauer, Andreas

Source: Leukemia & Lymphoma. Feb2005, Vol. 46 Issue 2, p167-175. 9p.

Determinants for transformation induced by the Axl receptor tyrosine kinase.

Authors: Burchert, Andreas Attar, Eyal C McCloskey, Patrick et al.

Source: Oncogene. 6/18/98, Vol. 16 Issue 24, p3177. 11p.

Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence.

Authors: Reinecke, Maximilian J. Ahlers, Gerrit Burchert, Andreas et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. 2022, Vol. 49 Issue 9, p3247-3256. 10p. 2 Charts, 2 Graphs.

CD82 (KAI1), a member of the tetraspan family, is expressed on early haemopoietic progenitor cells and up-regulated in distinct human leukaemias.

Authors: Burchert, Andreas Notter, Michael Menssen, Hans Dietrich et al.

Source: British Journal of Haematology. Dec99, Vol. 107 Issue 3, p494-504. 11p. 2 Diagrams, 5 Graphs.

Diffuse pneumatosis due to central venous catheterization in a patient with acute graft-versus-host disease.

Authors: Mikesch, Jan-Henrik Burchert, Andreas Kress, Oliver et al.

Source: Annals of Hematology. Oct2007, Vol. 86 Issue 10, p767-769. 3p. 1 Black and White Photograph.

Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis‐associated adhesion of ovarian cancer cells.

Authors: Neuhaus, Felix Lieber, Sonja Shinkevich, Veronika et al.

Source: Clinical & Translational Medicine. Apr2024, Vol. 14 Issue 4, p1-24. 24p.

Presentation of Chloromas in B-Mode Ultrasound and Contrast-Enhanced Ultrasound.

Authors: Trenker, Corinna Görg, Christian Burchert, Andreas et al.

Source: Ultrasound in Medicine & Biology. Sep2022, Vol. 48 Issue 9, p1933-1940. 8p.

Subjects: Myeloid sarcoma, Extramedullary diseases, Acute myeloid leukemia, Progenitor cells, Myeloid cells, Ultrasonic imaging, Myeloid leukemia, Differential diagnosis, Contrast media, Retrospective studies

Poor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia.

Authors: Wilhelm, Christian Neubauer, Andreas Burchert, Andreas

Source: Leukemia & Lymphoma. Oct2011, Vol. 52 Issue 10, p2031-2035. 5p. 1 Chart, 1 Graph.

Too much BCR-ABL to live on, but too little BCR-ABL to die on?

Authors: Burchert, Andreas Neubauer, Andreas Hochhaus, Andreas

Source: Blood. 3/22/2012, Vol. 119 Issue 12, p2965-2966. 2p.

VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML.

Authors: Kretschmer, Lydia Ruhnke, Leo Schliemann, Christoph et al.

Source: Annals of Hematology. Jul2025, Vol. 104 Issue 7, p3647-3654. 8p.

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.

Authors: Eckardt, Jan-Niklas Stölzel, Friedrich Kunadt, Desiree et al.

Source: Journal of Hematology & Oncology. 5/13/2022, Vol. 15 Issue 1, p1-13. 13p.

Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations – a registry based analysis.

Authors: Middeke, Jan M. Teipel, Raphael Röllig, Christoph et al.

Source: Leukemia & Lymphoma. Jun2021, Vol. 62 Issue 6, p1432-1440. 9p.

Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation.

Authors: Christen, Deborah Sohlbach, Kristina Metzelder, Stephan K. et al.

Source: Leukemia & Lymphoma. Aug2019, Vol. 60 Issue 8, p2056-2061. 6p.

A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation.

Authors: Bittrich, Max Kriegsmann, Katharina Tietze-Stolley, Carola et al.

Source: Transfusion Medicine & Hemotherapy. 2023, Vol. 50 Issue 6, p475-490. 16p.

Monitoring of acute myeloid leukemia patients after allogeneic stem cell transplantation employing semi-automated CD34+ donor cell chimerism analysis.

Authors: Hoffmann, Joerg Stabla, Kathleen Burchert, Andreas et al.

Source: Annals of Hematology. Feb2014, Vol. 93 Issue 2, p279-285. 7p.